Impact BioMedical, Inc. (IBO)
0.479
+0.02
(+3.88%)
USD |
NYAM |
Sep 01, 16:00
0.479
0.00 (0.00%)
After-Hours: 19:29
Impact BioMedical Total Long Term Debt (Quarterly) : 0.00 for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.00 |
| March 31, 2026 | 0.00 |
| December 31, 2025 | 0.00 |
| September 30, 2025 | 22.88M |
| June 30, 2025 | 22.35M |
| March 31, 2025 | 9.141M |
| December 31, 2024 | 8.878M |
| September 30, 2024 | 8.006M |
| June 30, 2024 | 13.45M |
| March 31, 2024 | 12.79M |
| December 31, 2023 | 12.07M |
| September 30, 2023 | 11.78M |
| June 30, 2023 | 11.75M |
| March 31, 2023 | 11.01M |
| Date | Value |
|---|---|
| December 31, 2022 | 9.529M |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 12.52M |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 7.934M |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 1.059M |
| September 30, 2020 | 0.0472M |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| September 30, 2019 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Enveric Biosciences, Inc. | 0.00 |
| LENZ Therapeutics, Inc. | 0.122M |
| ANI Pharmaceuticals, Inc. | 610.49M |
| Corcept Therapeutics, Inc. | 7.504M |
| Veru, Inc. | 1.908M |